---
figid: PMC8073512__ijms-22-04203-g001
figtitle: 'Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms
  of Action, Pharmacology, Safety, and Efficacy'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8073512
filename: ijms-22-04203-g001.jpg
figlink: /pmc/articles/PMC8073512/figure/ijms-22-04203-f001/
number: F1
caption: PARP-associated synthetic lethality. PARPi activity is based on the concept
  of synthetic lethality. BRCA mutant cells are deficient in the HR pathway when a
  PARPi is associated. In addition, SSB repair is inhibited and apoptosis is induced.
papertitle: 'Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms
  of Action, Pharmacology, Safety, and Efficacy.'
reftext: Giorgio Valabrega, et al. Int J Mol Sci. 2021 Apr;22(8):4203.
year: '2021'
doi: 10.3390/ijms22084203
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: ovarian cancer | olaparib | niraparib | rucaparib | safety | efficacy
automl_pathway: 0.8064705
figid_alias: PMC8073512__F1
figtype: Figure
redirect_from: /figures/PMC8073512__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8073512__ijms-22-04203-g001.html
  '@type': Dataset
  description: PARP-associated synthetic lethality. PARPi activity is based on the
    concept of synthetic lethality. BRCA mutant cells are deficient in the HR pathway
    when a PARPi is associated. In addition, SSB repair is inhibited and apoptosis
    is induced.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRCA1
  - BRCA2
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - SSB
---
